BIOS cover image

40. TechBio Era w/ Vik Bajaj - Managing Director @ Foresite Capital

BIOS

CHAPTER

Precision Medicine

In each one is precision medicine, the idea that we can do in oncol what we've done in oncology for a broader set of diseases. We have started several companies, i think, three of which are publicly announced. A fourth is about to be announced to morrow, and i can tell you about it. These companies are really in three areas. The genetic rearrangements responsible for tumarogenesis, or any of the hall marks of cancer, their role as causal drivers of disease has been unambiguously established now through two decades of cinomic and other studie. Also, those same genetic drivers are the targets for the drugs.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner